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TRPC6 is a ubiquitous and predominant isoform
expressed in vascular smooth muscle cells (VSMCs) and
has been implicated in the regulation of vascular tone and
remodelling via neurohormonal and mechanosensitive
mechanisms. Although these two mechanisms are gener-
ally thought to work independently, our recent investiga-
tion has revealed that TRPC6 channel is synergistically
activated by receptor and mechanical stimulations via the
phospholipase C/Gq-protein/diacylglycerol and phos-
pholipase A2/ω-hydroxylase/20-hydroxyeicosatetraenoic
acid pathways. Experiments with pressurized mesenteric
artery have suggested that this synergism likely contrib-
utes to enhanced myogenic responsiveness under near-
threshold receptor stimulation. Different lines of evidence
also suggest that TRPC6 channel is subject to both positive
and negative regulation via activation of Ca2+/ calmodu-
lin-dependent kinase (CAMKII), and protein kinases C
(PKC) and G (PKG); while CAMKII- and PKC-mediated
phosphorylation accelerates the time courses of TRPC6
activation and inactivation during receptor stimulation
respectively, activation of PKG via stimulation of the nitric
oxide or atrial natriuretic peptide/guanylate cyclase/cGMP
pathway tonically suppresses TRPC6 channel activity
through its phosphorylation on T69, regardless of recep-
tor or mechanical stimulation[1]. Interestingly, prolonged
activation of PKG (10–20 min) reactivated TRPC6 chan-
nel rendering it spontaneously active with loss of recep-
tor- and mechano-sensitivities. Disruption of actin
cytoskeleton by cytochalasin D treatment induced similar
consequences. It can be speculated that phosphorylation
of TRPC6 channel by PKG may not only cause an acute
tonic inhibition of the channel activation by neurohor-
monal and mechanical stimuli, but also induce a slow
transition between differential activation modes, presum-
ably altering the VSMC phenotype from 'contractile' to
'proliferative' ones.
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